A number of cytokines were tested for their ability to modulate HLA-DR antigen expression on normal human monocytes. IL 4, GM-CSF as well as IFN-gamma were able to increase HLA-DR antigen expression on monocytes. IFN-alpha was also able to augment HLA-DR antigen expression, but to a lesser degree. M-CSF, TNF-A, TNF-beta and IL 6 were not able to augment HLA-DR antigen expression. There were distinct patterns in the ability of different cytokines to augment class II histocompatibility antigen expression. IL 4 and GM-CSF selectively increased only HLA-DR and HLA-DP, but did not increase HLA-DQ antigens on monocytes. IFN-gamma, however, was able to augment the expression of HIA-DR, HLA-DP and HLA-DQ antigens. Combinations of IFN-gamma with either IL 4 or GM-CSF did not show any synergy for the augmentation of any of the class II antigens on monocytes.

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BD003010-02
Application #
3811203
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1990
Total Cost
Indirect Cost